Last updated: June 5, 2026

Back to directory

DeepHealth Breast Suite medical AI product profile

Breast imaging AI suite from DeepHealth that includes Saige-Dx and related mammography workflow modules for AI-assisted screening interpretation and population-health operations.

Screenshot of the official DeepHealth Breast Suite product page
Medical imaging and radiology

Best fit

Breast imaging programs evaluating FDA-cleared mammography AI alongside worklist, density, risk, and operations modules while keeping interpreting physicians accountable for final reads.

Primary use case
AI-supported mammography detection, density assessment, workflow triage, risk assessment, and breast imaging worklist support across modular Breast Suite applications
Audience
Breast imaging centers, radiology groups, population-health screening programs, mammography operations leaders, and health systems standardizing breast cancer screening workflows
Risk level
High
Pricing signal
Enterprise and imaging-network pricing; request current module availability, scanner compatibility, deployment model, support, and country-specific clearance details.
Official sources
6 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating DeepHealth Breast Suite as safe for a local clinical, operational, or research workflow.

Regulatory / FDASeparate each Breast Suite component before deployment because FDA clearance for Saige-Dx does not automatically cover risk assessment, breast ultrasound, BAC, viewer, or future suite modules.
PrivacyReview mammography image routing, cloud processing, PACS or worklist integration, user roles, support access, retention, audit logging, BAA terms, and regional data-processing commitments.
EvidencePilot against local mammography baselines for cancer detection, recall, reading time, density distribution, subgroup performance, scanner mix, and radiologist disagreement rather than relying on broad suite claims.
WorkflowBest governed as radiologist-reviewed breast imaging decision support with module-specific protocols, quality monitoring, override capture, escalation rules, and clear patient communication boundaries.

Where DeepHealth Breast Suite fits

DeepHealth describes Breast Suite as a modular AI-powered breast imaging suite; its product page notes FDA 510(k) clearance K251873 for Saige-Dx while also labeling some modules as pending clearance or not cleared for U.S. use. FDA summaries for Saige-Dx describe concurrent reading-aid use for qualified interpreting physicians reviewing screening DBT mammograms with compatible hardware.

Not for: Autonomous breast cancer diagnosis, assuming every Breast Suite module is cleared in every market, unsupported scanners or exam types, or replacing radiologist review and MQSA-governed quality workflows.

What to verify before using DeepHealth Breast Suite

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products